Xelpmoc Design Q3 FY26 Earnings Analysis
Published 5 Aug 2026 | IT - Software | Market Cap: ₹123 Cr
Price
₹83.28
Market Cap
₹123 Cr
Earnings Summary
- Expect gradual revenue traction over next few quarters as pilot projects in AgeTech monetize by Q3/Q4 FY '26. - Xelpmoc expects positive quarters ahead driven by advanced video analytics projects and AI integrations (Page 13).
📊 Revenue & Sales Performance
- Expect gradual revenue traction over next few quarters as pilot projects in AgeTech monetize by Q3/Q4 FY '26. - Signing up pilot projects for RELY product expected to monetize by Q4 FY '26. - Current corporate interest for services and solutions likely to increase, driving revenue growth. - DocuXray framework has about 2 customers now and growing; data science projects have around 4 customers currently. - Aim to turn EBITDA positive or break even within next 1–2 quarters. - Focus on expanding product offerings for elder care and legal/financial sectors to boost revenues. - Exploring markets beyond India, with clients overseas especially for DocuXray and data science solutions. - Market environment improving with expected resurgence in startups and clarity over next 2–3 quarters, likely to aid growth. - Large corporate clients adopting AI solutions rapidly, indicating strong market pull and future sales potential.
📈 Profitability & Margins
- Xelpmoc expects positive quarters ahead driven by advanced video analytics projects and AI integrations (Page 13). - Pilot projects, especially in AgeTech (RELY product), are expected to monetize starting Q3/Q4 FY '26 (Pages 2, 6, 11). - The company targets profitability or breakeven in the next couple of quarters by focusing on product development (Page 10). - Revenue traction is anticipated to gradually increase over the next few quarters due to growing corporate segment engagement (Page 2). - Current EBITDA is negative, but operating costs are expected to stabilize moving forward (Page 2). - Xelpmoc is emphasizing sustainable revenue generation via corporate data science and AI solutions rather than rapid startup investments (Pages 4, 9, 11). - Expansion is not limited to India but includes overseas markets for products like DocuXray (Page 11).
🏗️ Capital Expenditure Plans
- Xelpmoc is focusing on product development, especially in AgeTech (RELY product) and DocuXray framework, with ongoing additions and new products planned based on market needs. - The company is conducting pilot projects in AgeTech, expected to monetize by Q3-Q4 FY '26, indicating ongoing capital allocation towards product launches and market expansion. - They are selectively investing in startups showing promise, with a cautious approach to new investments due to the current challenging startup funding environment. - Strategic investments include continuing support to portfolio companies like Mihup, Woovly, Snaphunt, and Pencil, leveraging these for longer-term value creation; e.g., Mihup plans IPO subject to approvals. - No explicit new large-scale capex mentioned, but focus is on sustainable, product-driven growth and enhancing their technology stack to achieve profitability in the coming quarters.
💰 Fundraising & Capital Structure
- The transcript does not mention any current or planned fundraising through debt or equity by Xelpmoc Design and Tech Limited. - Focus is on achieving profitability and monetization of products like RELY and DocuXray within the next 1-2 quarters. - The company is concentrating on sustainable growth from existing operations rather than new capital raises. - Management emphasizes using time and creativity rather than additional investments for growth, indicating no imminent fundraising plans. - No explicit statements on plans for raising capital via equity or debt were made in the Q2 FY '26 earnings call.
📋 Order Book & Pipeline
- Xelpmoc currently has several pilot projects and POCs (Proof of Concepts) underway, particularly in the AgeTech sector (RELY product) and other sectors like insurance and tech. - RELY pilot projects are expected to be signed by December or early Q4 FY '26, with monetization expected in Q4 FY '26. - DocuXray framework has a couple of clients already onboard, including from India and overseas, with billing based on the number of documents processed rather than licenses. - Data science projects currently have about 4 customers. - The conversion of POCs into revenue is taking longer than initially expected but is progressing, with large clients showing strong interest and prompt conversion. - Overall, the company's orderbook consists of early-stage pilots and ongoing POCs, with expected revenue traction and monetization in the coming quarters.
Key Metrics
Frequently Asked Questions
What were Xelpmoc Design Q3 FY26 results?
- Expect gradual revenue traction over next few quarters as pilot projects in AgeTech monetize by Q3/Q4 FY '26. - Xelpmoc expects positive quarters ahead driven by advanced video analytics projects and AI integrations (Page 13).
What is Xelpmoc Design share price analysis?
Xelpmoc Design currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹123. Investors should review the full earnings analysis for detailed insights.
Is Xelpmoc Design planning capital expenditure?
- Xelpmoc is focusing on product development, especially in AgeTech (RELY product) and DocuXray framework, with ongoing additions and new products planned based on market needs.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
